Stocks Telegraph

ABVC Stock Price History and Quote Analysis: Insights for Investors

NASDAQ:ABVC

ABVC BioPharma, Inc.

$0.69
-0.014-1.99%
At Close 4:00 PM
$0.71
0.02+2.90%
Pre-Market 07:04 PM
63.71
BESG ScoreESG Rating

ABVC FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

ABVC Income Statement


A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

Date2024-06-302024-03-312023-12-312023-09-302023-06-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202320232023
periodQ2Q1Q4Q3Q2
revenue117.142K1.205K2.165K15.884K6.109K
cost of revenue13.495K1.563K146.788K29.614K72.981K
gross profit103.647K-358.00-144.623K-13.73K-66.872K
gross profit ratio0.885-0.297-66.80-0.864-10.946
research and development expenses40.401K69.066K72.185K141.31K514.442K
general and administrative expenses1.053M3.376M1.752M2.00M1.613M
selling and marketing expenses-13.305K-1.286K-7.582K00
selling general and administrative expenses1.04M3.375M1.745M2.00M1.613M
other expenses22.671K30.485K16.558K-10.769K38.328K
operating expenses1.08M3.444M1.817M2.141M2.127M
cost and expenses1.094M3.446M1.964M2.171M2.20M
interest income27.141K4.049K37.483K40.246K55.041K
interest expense260.032K684.683K1.103M1.219M114.752K
depreciation and amortization13.305K1.286K7.582K7.459K6.997K
ebitda-963.34K-3.443M-1.954M-2.118M-2.093M
ebitda ratio-8.224-2.857K-902.554-133.338-342.687
operating income-976.64K-3.444M-1.962M-2.155M-2.194M
operating income ratio-8.337-2.858K-906.055-135.663-359.116
total other income expenses net-406.943K-536.629K-1.193M-35.828K20.023K
income before tax-1.384M-3.981M-3.154M-3.369M-2.234M
income before tax ratio-11.811-3.304K-1.457K-212.105-365.613
income tax expense-110.894K-3.933M175.31K-999.0081.695K
net income-1.013M-3.933M-3.111M-3.318M-2.264M
net income ratio-8.645-3.264K-1.437K-208.859-370.521
eps-0.089-0.40-0.39-0.82-0.68
eps diluted-0.089-0.40-0.39-0.82-0.68
weighted average shs out11.321M9.736M7.94M4.055M3.309M
weighted average shs out dil11.321M9.736M7.94M4.055M3.309M
Graph

ABVC Balance Sheet


Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

Date2024-06-302024-03-312023-12-312023-09-302023-06-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202320232023
periodQ2Q1Q4Q3Q2
cash and cash equivalents742.769K659.002K716.78K500.069K99.29K
short term investments75.683K75.916K79.312K68.521K76.787K
cash and short term investments818.452K734.918K796.092K568.59K176.077K
net receivables1.27M899.93K759.566K1.161M1.162M
inventory000620.868K-583.349K
other current assets100.81K159.602K101.051K143.127K1.374M
total current assets2.19M1.794M1.657M2.494M2.129M
property plant equipment net8.536M8.657M8.779M8.854M1.564M
goodwill00000
intangible assets00000
goodwill and intangible assets00000
long term investments2.499M2.824M3.093M2.677M831.706K
tax assets00034.256K35.472K
other non current assets1.409M1.411M1.416M2.533M4.76M
total non current assets12.444M12.892M13.287M14.098M7.192M
other assets00000
total assets14.634M14.686M14.944M16.592M9.32M
account payables0108.11K112.946K-79.501K-79.501K
short term debt2.508M2.395M2.044M1.245M1.273M
tax payables0108.11K112.946K00
deferred revenue79.50K79.50K79.50K79.501K79.501K
other current liabilities3.961M4.051M3.696M4.118M4.50M
total current liabilities6.549M6.634M5.932M5.363M5.773M
long term debt228.802K318.153K407.457K2.161M3.909M
deferred revenue non current00000
deferred tax liabilities non current00000
other non current liabilities27.68K21.68K21.68K5.68K5.68K
total non current liabilities256.482K339.833K429.137K2.167M3.915M
other liabilities00000
capital lease obligations228.802K318.153K407.457K899.817K999.645K
total liabilities6.805M6.973M6.362M7.53M9.687M
preferred stock00000
common stock12.052K10.698K7.94K4.823K3.308K
retained earnings-70.366M-69.353M-65.42M-62.309M-58.992M
accumulated other comprehensive income loss466.932K233.323K516.387K519.123K534.205K
other total stockholders equity78.18M77.127M73.735M70.885M58.075M
total stockholders equity8.293M8.018M8.84M9.10M-379.315K
total equity7.828M7.713M8.582M9.062M-367.01K
total liabilities and stockholders equity14.634M14.686M14.944M16.592M9.32M
minority interest-465.165K-305.121K-257.077K-38.259K12.305K
total investments2.575M2.90M3.172M2.746M831.706K
total debt2.737M2.713M2.451M3.406M5.182M
net debt1.994M2.054M1.734M2.906M5.083M
Graph

ABVC Cash Flow


A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

Date2024-06-302024-03-312023-12-312023-09-302023-06-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202320232023
periodQ2Q1Q4Q3Q2
deferred income tax00151.387K-117.414K81.695K
stock based compensation412.741K2.545M225.739K817.74K225.74K
change in working capital-514.367K160.721K-146.825K1.792K938.161K
accounts receivables-378.251K-140.364K-474.239K9.70K68.226K
inventory0068.515K00
accounts payables00112.946K00
other working capital-23.17K301.085K145.953K-7.908K869.935K
other non cash items880.144K3.312M2.411M1.30M162.805K
net cash provided by operating activities-1.038M-602.001K-461.997K-1.359M-899.827K
investments in property plant and equipment0021.201K-21.201K0
acquisitions net00000
purchases of investments00154.173K-52.583K-440.575K
sales maturities of investments00000
other investing activites00-21.201K00
net cash used for investing activites00154.173K-73.784K-440.575K
debt repayment-24.326K-410.935K-92.646K-2.321M-64.199K
common stock issued737.50K394.071K-22.69K1.05M0
common stock repurchased00000
dividends paid00000
other financing activites131.039K1.357M-1.782M606.54K-31.587K
net cash used provided by financing activities892.866K805.006K69.957K1.657M-31.587K
effect of forex changes on cash229.324K-260.783K-166.29K154.917K322.30K
net change in cash83.767K-57.778K-404.157K378.748K-1.05M
cash at end of period742.769K659.002K716.78K1.121M742.189K
cash at beginning of period659.002K716.78K1.121M742.189K1.792M
operating cashflow-1.038M-602.001K-461.997K-1.359M-899.827K
capital expenditure0021.201K-21.201K0
free cash flow-1.038M-602.001K-440.796K-1.38M-899.827K
Graph

Frequently Asked Questions

How did ABVC BioPharma, Inc. do last quarter? What was its Total Revenue and Cost of Revenue?

A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, ABVC generated $117.14K in revenue last quarter, while its costs came in at $13.50K.

Last quarter, how much Gross Profit did ABVC BioPharma, Inc. report?

A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. ABVC BioPharma, Inc. reported a $103.65K Gross Profit for the quarter ended Jun 30, 2024.

Have ABVC's Total Operating Expenses and Operating Income been favorable recently?

Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. ABVC incurred $1.08M worth of Operating Expenses, while it generated -$976.64K worth of Operating Income.

How much Net Income has ABVC posted recently?

The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from ABVC BioPharma, Inc., the company generated -$1.01M in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.

At the end of the last quarter, how much Cash and Equivalents did ABVC BioPharma, Inc. have?

The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to ABVC BioPharma, Inc. as of the end of the last quarter was $742.77K.

What are ABVC's Total Net Receivables for the last quarter?

Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, ABVC had Total Net Receivables of $1.27M.

In terms of Total Assets and Current Assets, where did ABVC BioPharma, Inc. stand at?

An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of ABVC were $2.19M, while the Total Assets stand at $14.63M.

As of the last quarter, how much Total Debt did ABVC BioPharma, Inc. have?

The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of ABVC's debt was $2.74M at the end of the last quarter.

What were ABVC's Total Liabilities during the last reported quarter?

A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, ABVC reported total liabilities of $6.81M.

How much did ABVC's Working Capital change over the last quarter?

Working Capital Change for ABVC was -$514.37K over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.

ABVC generated how much cash from operating activities?

An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. ABVC generated -$1.04M of Cash from Operating Activities during its recently reported quarter.

What was ABVC's latest reported Net Change in Cash?

An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. ABVC reported a $83.77K Net Change in Cash in the most recent quarter.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Log in to gain access to powerful insights powered by AI and Wallstreet analysts.

Login Form

OR
stockstelegraph

Join to access AI-powered insights from top Wall Street analysts.

Signup Form

OR
stockstelegraph

Log in to gain access to powerful insights powered by AI and Wallstreet analysts.

Reset Password Form

stockstelegraph

Subscribe to gain access to powerful insights powered by AI and Wallstreet analysts.

This feature is only available to Premium Users.

Subscribe Now